BETAGAN 0.5 %, eye drop solution in a single-dose container 60 single-dose containers of 0.4 ml
Active ingredients: Levobunolol hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution60 single-dose containers of 0.4 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETAGAN 0,5 % , collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 60 récipient(s) unidose(s) polyéthylène de 0,4 ml
- Marketing authorisation holder
- ABBVIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63572025CIP73458610CIP133400934586101Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LÉVOBUNOLOLcollyre | 0,5 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.